LoadingTRC
TISCH DANIEL R; TOWERVIEW LLC reported 2,023 shares of Common Stock in TEJON RANCH CO as grants or awards dated 2026-10-20. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
ERIE
Edwards William David reported Other (see filing) in ERIE INDEMNITY CO: 1.556 units of Directors' Deferred Compensation Share Credits (derivative), dated 2026-10-20. The full Form 4 contains 1 transaction entry.
HRTX
Collard Craig A reported Exercise or conversion in HERON THERAPEUTICS, INC. /DE/: 13797 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
HRTX
Forbes William P reported Exercise or conversion in HERON THERAPEUTICS, INC. /DE/: 3874 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
HRTX
Duarte Ira reported Exercise or conversion in HERON THERAPEUTICS, INC. /DE/: 3874 units of Common Stock, dated 2026-10-19. The full Form 4 contains 3 transaction entries.
CIB
Jaramillo Mejia Ricardo reported Grant or award in Grupo Cibest S.A.: 244.62 units of Units in Grupo Cibest Equity Securities Fund (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
CIB
Toro Valencia Juan Esteban reported Grant or award in Grupo Cibest S.A.: 441.77 units of Units in Grupo Cibest Equity Securities Fund (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
CIB
Mejia Cardona Andres Felipe reported Grant or award in Grupo Cibest S.A.: 640.58 units of Units in Grupo Cibest Equity Securities Fund (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
CIB
Zapata Zuluaga Nicolas reported Grant or award in Grupo Cibest S.A.: 457.66 units of Units in Grupo Cibest Equity Securities Fund (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
CIB
Restrepo Echavarria Luis Fernando reported Grant or award in Grupo Cibest S.A.: 373.69 units of Units in Grupo Cibest Equity Securities Fund (derivative), dated 2026-10-19. The full Form 4 contains 1 transaction entry.
ASB
Haddad Michael J reported Grant or award in ASSOCIATED BANC-CORP: 727.398 units of Phantom Stock Unit (derivative), dated 2026-10-20. The full Form 4 contains 1 transaction entry.
YORW
Velazquez David M reported Purchase in YORK WATER CO: 1287.529 units of Common Stock, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
YORW
Brossman Douglas S reported Purchase in YORK WATER CO: 32.188 units of Common Stock, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
AEP
Cannon Douglas A reported Grant or award in AMERICAN ELECTRIC POWER CO INC: 20044 units of Resticted Stock Units, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
AEP
Berntsen Robert reported Grant or award in AMERICAN ELECTRIC POWER CO INC: 20044 units of Resticted Stock Units, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
UXIN
Dai Kun reported Purchase in Uxin Ltd: 5541 units of American depositary shares, dated 2026-10-20. The full Form 4 contains 1 transaction entry.
OWLS
WANG CHUN KAI reported Purchase in OBOOK HOLDINGS INC.: 12192 units of Class A Common Shares, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
VLN
Rozenberg Haine Yael reported Sale in Valens Semiconductor Ltd.: 1458 units of Ordinary Shares, dated 2026-10-19. The full Form 4 contains 1 transaction entry.
SCISX
MA Eagle II Holdings Fund reported Purchase in MA Specialty Credit Income Fund: 96930.533 units of Common Shares of Beneficial Interest, dated 2026-10-16. The full Form 4 contains 1 transaction entry.
Urquhart Nathan reported Grant or award in Coatue Innovative Strategies Fund: 39357.00 units of Class I Shares, dated 2026-10-16. The full Form 4 contains 1 transaction entry.
Sacks Eric reported Grant or award in Coatue Innovative Strategies Fund: 11807.00 units of Class I Shares, dated 2026-10-16. The full Form 4 contains 1 transaction entry.
RNTZ
Tang Teck Shen reported Other (see filing) in Rantizo: 69375 units of Class B Ordinary Shares, dated 2026-10-09. The full Form 4 contains 1 transaction entry.
Egerton Capital (UK) LLP disclosed 23 reported positions as of 2026-09-30. The 13F-HR was filed on Oct 20, 2026.
ZS
Geller Adam reported 19,859 shares of Common Stock in Zscaler, Inc. as grants or awards dated 2026-10-19. The Form 4 was disclosed on Oct 21, 2026. These were stock awards, not open-market purchases.
